Inceptionr LLC Vertex Pharmaceuticals Inc Transaction History

Inceptionr LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$407.69 - $446.08 $727,726 - $796,252	1,785 Added 217.95%	2,604 $1.09 Billion
Q4 2023 Feb 08, 2024	SELL	$343.0 - $410.68 $638,666 - $764,686	-1,862 Reduced 69.45%	819 $333 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $494,419 - $529,916	1,462 Added 119.93%	2,681 $932 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $383,277 - $428,978	1,219 New	1,219 $429 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

Stay updated on Inceptionr LLC with notifications on news.